Oscar Health, Inc. (NYSE:OSCR) Given Average Recommendation of “Moderate Buy” by Brokerages

Oscar Health, Inc. (NYSE:OSCR) has been given an average rating of “Moderate Buy” by the eight ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokerages that have issued a report on the stock in the last year is $24.00.

Several equities analysts have recently issued reports on OSCR shares. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a “neutral” rating and a $23.00 price objective on the stock. Piper Sandler restated an “overweight” rating and set a $28.00 target price on shares of Oscar Health in a report on Tuesday, September 10th.

Oscar Health Price Performance

Shares of OSCR opened at $18.09 on Tuesday. Oscar Health has a 52-week low of $5.65 and a 52-week high of $23.79. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.26. The business’s 50 day moving average is $18.74 and its two-hundred day moving average is $18.43.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, August 7th. The company reported $0.20 EPS for the quarter, topping analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. Oscar Health had a return on equity of 1.86% and a net margin of 0.25%. Oscar Health’s quarterly revenue was up 44.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.07) EPS. As a group, equities research analysts predict that Oscar Health will post 0.01 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares of the company’s stock, valued at $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. In related news, insider Mario Schlosser sold 3,198 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $57,532.02. Following the transaction, the insider now owns 76,982 shares of the company’s stock, valued at approximately $1,384,906.18. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the transaction, the chief accounting officer now owns 140,648 shares in the company, valued at $2,530,257.52. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 169,569 shares of company stock worth $3,007,069. Corporate insiders own 25.11% of the company’s stock.

Hedge Funds Weigh In On Oscar Health

Large investors have recently bought and sold shares of the stock. Avalon Trust Co acquired a new stake in shares of Oscar Health during the 1st quarter valued at about $69,000. Point72 Hong Kong Ltd acquired a new stake in Oscar Health during the second quarter valued at approximately $78,000. Quest Partners LLC bought a new stake in shares of Oscar Health in the 2nd quarter valued at approximately $93,000. Amalgamated Bank raised its holdings in shares of Oscar Health by 27.7% in the 2nd quarter. Amalgamated Bank now owns 6,727 shares of the company’s stock worth $106,000 after buying an additional 1,458 shares in the last quarter. Finally, Optimum Investment Advisors bought a new position in shares of Oscar Health during the 3rd quarter worth approximately $142,000. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.